Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

August 7, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

July 13, 2026July 13, 2026

Why Do We Age? The Biology Of Ageing Explained

1
October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

2
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

3
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

4
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

5
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Neuropilin-1 (NRP-1) influencing SARS-CoV-2 to infect human cells more abruptly

Government National Cancer Institute Life Science JRF Recruitment

Molecular Archaeology-Let’s rewrite the History with ancient DNA

Neuropilin-1 (NRP-1) influencing SARS-CoV-2 to infect human cells more abruptly
  • BiotechToday
  • World

Neuropilin-1 (NRP-1) influencing SARS-CoV-2 to infect human cells more abruptly

bioxone October 22, 2020October 22, 2020

Devyani Goswami, Amity University Kolkata

The spike proteins of the SARS-CoV-2 have been always the subject of interest in how it attaches to the human cells and causes the disease. Angiotensin-converting enzyme 2 (ACE2) is identified as the functional receptor for SARS-CoV (the virus observed in 2003); they are present in the epithelia of the lungs and small intestine. 

The major difference between SARS-CoV-2 and SARS-CoV is the presence of a polybasic furin-type cleavage site, RRAR^S, at the S1/S2 junction of the former spike protein (S) which is absent in the later. Proteolytic cleavage of RRAR^S by furin exposes a conserved C-terminal motif RXXROH (R – arginine/lysine, X – any amino acid) in the S protein. These C-terminal sequences (CendR) binds and activates neuropilin (NRP1 and NRP2) receptors in cells. 

The research was conducted on modified HEK-293T cells. ACE2 when expressed alone caused the infection to cells, while NRP-1 hardly caused any harm. Though, “co-expression with ACE2 and TMPRSS2 enhanced infection”. Monoclonal antibodies (mAbs) were designed to test the specificity of the NRP-1 dependent virus entry, which “blocked the extracellular b1b2 domain of NRP-1”. The mAbs failed to bind to the mutant b1b2 domain. Concludingly, TRP-1 is a host factor.

The sequence of SARS-CoV-2 spike proteins resembles a human protein that binds to NRP-1, by a small sequence of amino acid.  Thus, the spike proteins of SARS-CoV-2 does indeed bind to NRP-1. “If you think of ACE2 as a door lock to enter cells, then NRP-1 could be the factor that directs the virus to the door. ACE2 is expressed at low levels in most cells. Thus, it is not easy for the virus to enter. Other factors like NRP-1 guide the virus to the door”. Although SARS-CoV-2 can enter into the host cell independently of the ACE2 when loads of the virus are high.

The authors concluded that it is too early to decide whether blocking NRP-1 directly could be a therapeutic approach, as this could lead to side effects. Further studies are solicited for this approach.

Also read: Fetus in Fetu analysis by modern Multimode Ultrasound

 REFERENCE: 1) Neuropilin-1 is a host factor for SARS-CoV-2 infection

https://science.sciencemag.org/content/early/2020/10/19/science.abd3072

2) Neuropilin-1 Facilitates SARS-CoV-2 cell entry and infectivity

https://science.sciencemag.org/content/early/2020/10/19/science.abd2985

3) SARS-CoV-2 uses a second receptor, Neuropilin-1, to infect human cells https://www.genengnews.com/news/sars-cov-2-uses-a-second-receptor-neuropilin-1-to-infect-human-cells/

  • Why Do We Age? The Biology Of Ageing Explained
  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged Angiotensin-converting enzyme 2 (ACE2) COVID-19 Monoclonal antibodies (mAbs) Neuropilin-1 SARS-CoV-2 spike proteins (S)

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • Biotechnopedia
  • DNA-Tales

Molecular Archaeology-Let’s rewrite the History with ancient DNA

bioxone October 22, 2020

Sayanti Pal, Amity University Kolkata Until the 1980s most of the researchers used to believe that no detectable genetic material is preserved in archaeological remains due to the rapid decay of bio-organic molecules. The invention of different molecular techniques made possible the detection and characterization of organic compounds present in archaeological remains. Reading the DNA sequence of […]

Molecular Archaeology

Related Post

  • BiotechToday
  • World

A novel approach to reduce graft-vs-host disease

bioxone July 17, 2021July 16, 2021

Monika R, PSG College of Technology, Coimbatore Stem cell transplantation (SCT) has emerged as the treatment of choice for most people suffering from disorders of the hematopoietic and immune systems or cancer. Each year, 12,000-15,000 allogeneic SCTs are estimated worldwide, with a continuing growth rate of 10-20% per year.  Allogeneic SCT is a medical procedure […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

How statins lower the death rate in COVID-19 patients

bioxone July 19, 2021July 19, 2021

Saakshi Bangera, DY Patil School of Biotechnology and Bioinformatics Despite the improving research methodologies and treatments, COVID-19 continues to spread, causing deaths and morbidity across the world. It has been found that statins can potentially decrease the severity of COVID-19. However, this field has been less researched due to limited size and region-centred studies.  Statins […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Depressive disorders and Pharmacotherapy: New info revealed!

BioTech Today July 25, 2021July 24, 2021

Soumya Shraddhya Paul, Amity University, Noida In 2017, depressive disorders were the third biggest cause of non-fatal illness burden worldwide. In the treatment of depressive disorders, pharmacotherapy is an essential component. As of now, the treatment consists of monotherapy using second-generation antidepressants, such as selective serotonin reuptake inhibitors (SSRIs), serotonin and norepinephrine reuptake inhibitors (SNRIs), […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

Why Do We Age? The Biology Of Ageing Explained

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy